37 studies found for:    PDC
Show Display Options
Rank Status Study
1 Completed Partners in Dementia Care
Conditions: Dementia;   Alzheimer Disease
Interventions: Behavioral: Care Coordination in Primary Care;   Behavioral: Care Coordination in Alz. Association
2 Completed Dose-Finding Study of PDC31 in Patients With Primary Dysmenorrhea
Condition: Dysmenorrhea
Intervention: Drug: PDC31
3 Recruiting A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression
Condition: Major Depressive Disorder
Interventions: Drug: PDC-1421;   Drug: Placebo
4 Completed A Phase II Clinical Study of PDC-748 in Patients With Acute Cough
Condition: Acute Cough
Intervention: Drug: PDC-748
5 Completed A Clinical Trial to Evaluate the Efficacy and Safety of PDC-339 for the Treatment of Acute Erosive Gastritis
Condition: Erosive Gastritis
Interventions: Drug: PDC339;   Drug: Placebo
6 Recruiting Plasmacytoid Dendritic Cell Vaccines in Metastatic Melanoma Patients
Condition: Melanoma
Intervention: Biological: PDC
7 Recruiting C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Intervention: Drug: rhC1INH or pdC1INH
8 Active, not recruiting Tailored Intervention to Improve Patient Adherence to Secondary Stroke Prevention Medication
Conditions: Stroke;   Transient Ischemic Attack
Interventions: Behavioral: Complex tailored intervention;   Behavioral: Usual care
9 Completed An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' Trial
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Technosphere®/ Insulin and MedTone™ Inhaler
10 Completed Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor
Condition: Medication Non-Adherence
Interventions: Behavioral: No Patient Counseling;   Behavioral: Adherence Counseling
11 Completed Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment
Conditions: Breast Neoplasms;   Prostatic Neoplasms;   Multiple Myeloma;   Osteolysis
Intervention: Drug: Clodronate (Bonefos, BAY94-8393)
12 Terminated
Has Results
A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF
Condition: Hematologic Diseases
Interventions: Drug: G-CSF;   Drug: GM-CSF
13 Recruiting International PFO Consortium
Conditions: Stroke;   Transient Ischemic Attack
Interventions: Drug: Antithrombotic treatment;   Device: percutaneous device closure of PFO
14 Recruiting Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: pomalidomide;   Drug: carfilzomib;   Drug: dexamethasone
15 Completed Additional KIF6 Risk Offers Better Adherence to Statins
Conditions: Cardiovascular Diseases;   Dyslipidemia
Intervention: Genetic: KIF6 genetic test
16 Completed Intimate Partner Violence (IPV)Screening in Health Care Clinics in Rural South Carolina
Condition: Partner Abuse
Interventions: Behavioral: Onsite IPV specialist;   Behavioral: Empowerment focused intervention
17 Withdrawn Improving Medication Adherence in Hypertensive Patients
Condition: Hypertension
Intervention: Behavioral: Electronic Intervention
18 Not yet recruiting The Effect of Synching Prescription Refills on Adherence
Conditions: Hypertension;   Hypercholesterolemia;   Diabetes;   Medication Adherence
Intervention: Behavioral: Refill synch
19 Completed Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear
Condition: Corneal Staining
Interventions: Device: ReNu Multiplus multipurpose disinfecting solution;   Device: Control
20 Recruiting Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
Conditions: Colorectal Cancer;   Gastric Adenocarcinoma;   Esophageal Cancer;   Hepatocellular Carcinoma;   Non-small Cell Lung Cancer;   Small Cell Lung Cancer;   Ovarian Epithelial Cancer;   Breast Cancer;   Hormone-refractory Prostate Cancer;   Pancreatic Ductal Adenocarcinoma;   Head and Neck Cancers- Squamous Cell;   Renal Cell Cancer;   Bladder Cancer
Intervention: Drug: IMMU-132

Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results
Indicates status has not been verified in more than two years